Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Softheon Expands to Artificial Intelligence in Care Management for Health Plans through Acquisition of NextHealth Technologies
Softheon, a leading cloud-based eligibility, enrollment, and billing provider for health plans and government agencies, has acquired […]
GSK Completes Acquisition of Sierra Oncology
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Sierra Oncology, Inc. […]
Pfizer Completes Acquisition of ReViral
Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of ReViral, a privately […]
Ginkgo Bioworks Acquires Bitome, an Integrated Metabolite Monitoring Platform
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced that it has […]
GSK to Acquire Clinical-stage Biopharmaceutical Company Affinivax, Inc.
GSK plc (LSE/NYSE: GSK) today announced that it has entered into a definitive agreement to […]
Apiary Medical, Inc. Acquires Manus Medical LLC
Apiary Medical, Inc. today announced the strategic acquisition of Manus Medical LLC, one of the […]
Sedgwick Acquires Orchid Medical
Sedgwick, a leading global provider of technology-enabled risk, benefits and integrated business solutions, announced it […]
Hertility Acquires Competitor Grip as the Two Female-founded Companies Join Forces in a United Goal to Revolutionise Women’s Health
Today, women’s health company Hertility is announcing the acquisition of Netherlands-based fertility and hormone testing […]
ArisGlobal Acquires Boehringer Ingelheim’s Signal Analytics Engine, Bringing Enhanced and Unmatched Pharmacovigilance Capabilities to Life Sciences Industry
ArisGlobal, the global market leader in drug safety solutions worldwide, and Boehringer Ingelheim, a leading […]
Pfizer to Acquire Biohaven Pharmaceuticals
Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more